Clinical trial
Effects Of DP-b99 On Neurological Function In Subjects With Acute Ischemic…
NCT00190047 · D-Pharm Ltd., Industry · Completed
Key facts
| NCT number | NCT00190047 |
|---|---|
| Title | Effects Of DP-b99 On Neurological Function In Subjects With Acute Ischemic Hemispheric Stroke |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Study To Evaluate The Effects Of DP-b99 On Neurologic Function And Disability In Subjects With Acute Ischemic Hemispheric Stroke |
| Lead sponsor | D-Pharm Ltd., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain Ischemia, Stroke, Cerebrovascular Disorders |
| Intervention type | Drug |
| Interventions | DP-b99 |
| Enrollment | 150 |
| Start date | Feb 1, 2005 |
| Completion | Oct 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Nov 26, 2007 |
| Countries | Germany, Israel |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: